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Restrictive mitral annuloplasty in refractory cardiogenic shock with
acute postinfarction mitral insufficiency and intact papillary muscle
J. Braun, MD, P. G. Voigt, MD, M. I. M. Versteegh, MD, and R. A. E. Dion, MD, Leiden, The Netherlands
Acute severe mitral insufficiency after myocardial in-farction usually results from rupture of a papillarymuscle, which should be treated on an emergencybasis with mitral valve repair or replacement. In the
case of acute postinfarction mitral regurgitation with intact papil-
lary muscle, no consensus exists, even with regard to the indication
for surgery.
Restrictive mitral annuloplasty (RMA) has been applied in
chronic ischemic mitral insufficiency, with encouraging midterm
results.1,2 In this report, we describe 2 patients in whom RMA was
applied as a lifesaving procedure in the presence of refractory
cardiogenic shock in postinfarction mitral insufficiency with intact
papillary muscle.
Clinical Summaries
PATIENT 1. A 55-year-old woman had an acute inferior wall infarc-
tion with cardiogenic shock. She received an intra-aortic balloon
pump (IABP) and inotropes and was intubated. Coronary angiog-
raphy revealed occlusion of the right coronary and circumflex
arteries. Transesophageal echocardiography (TEE) showed grade 4
mitral insufficiency resulting from systolic restrictive motion of
both leaflets (Carpentier type IIIb; Figures 1 and 2). The regurgi-
tation jet was slightly eccentric because of the more restrictive
posterior leaflet. Because of further hemodynamic deterioration,
we decided to attempt correction of the mitral regurgitation as a
lifesaving procedure.
During the operation, a fresh infarction of the posterolateral
wall involving the posterior papillary muscle was observed. The
subvalvular apparatus was intact, and there was no structural
anomaly of the mitral valve leaflets. RMA was performed with a
size 28 Carpentier-Edwards Physioring (Baxter Healthcare Corpo-
ration CardioVascular Group, Irvine, Calif), thereby downsizing
the prosthetic ring by two sizes. Tentative revascularization of the
circumflex and right coronary artery territory was performed with
a sequential saphenous vein graft. The patient was weaned from
extracorporeal circulation with inotropic support (epinephrine at
0.22 g/kg/min, dobutamine at 15 g/kg/min, dopamine at 8
g/kg/min, and enoximon at 4 g/kg/min). Intraoperative TEE
showed trivial mitral regurgitation with a mean transvalvular mi-
tral gradient of 3 mm Hg (mitral valve surface area 2 cm2) and
a leaflet coaptation height of 9 mm.
Troponin T rose to 22 g/L on day 1. The IABP was removed
after 8 days. The patient was discharged after 23 days. Nine
months after surgery, she is in New York Heart Association
functional class I, with no mitral insufficiency on echocardio-
graphic follow-up.
PATIENT 2. A 69-year-old woman was referred because of
hemodynamic deterioration 3 days after an inferior wall infarc-
tion. Coronary angiography revealed occlusion of the right
coronary artery. During balloon angioplasty, the patient went
into cardiogenic shock, was resuscitated, and received an IABP.
Troponin T rose to 19 g/L. TEE showed grade 4 mitral
regurgitation as a result of restrictive leaflet motion in systole
(Carpentier IIIb).
Initially, hemodynamic stabilization was obtained with ino-
tropes in addition to the IABP. Three weeks later, the patient
could not yet be weaned from mechanical ventilation. She
acquired gram-negative sepsis, and during exchange of the
IABP catheter she suffered hemodynamic collapse and was
again resuscitated. Apart from nonoliguric renal insufficiency,
she had neither major organ dysfunction nor neurologic com-
plications, but she required continuous administration of epi-
nephrine at 0.20 g/kg/min, dobutamine at 10 g/kg/min, and
enoximon at 2 g/kg/min. In an attempt to overcome this
deadlock situation, we decided to try to correct the mitral
insufficiency 27 days after the initial infarction. We performed
RMA with a size 26 (instead of 30) Physioring. The patient
could then be weaned from extracorporeal circulation with the
same inotropic support. Postoperative TEE showed no mitral
insufficiency, with a mean transvalvular gradient of 2 mm Hg
and a leaflet coaptation height of 9 mm.
The postoperative course was uneventful. The IABP was re-
moved on day 7. The patient was extubated after 20 days and was
discharged after 32 days. Two months after surgery, she is in New
York Heart Association functional class II, with grade 1 mitral
insufficiency on echocardiography.
Discussion
Cardiogenic shock in the setting of postinfarction mitral insuffi-
ciency portends a poor prognosis, with approximately 55% in-
hospital mortality in the SHOCK trial.3 Coronary revascularization
with or without mitral valve surgery in that study showed a
somewhat reduced but still high mortality of 40%, versus 71% in
nonsurgically treated patients. Most patients who did not undergo
surgery could not be stabilized and died. Thus the timing of
surgery may be important in determining outcome, and early
surgery before or immediately at the onset of cardiogenic shock
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might save lives. Our first patient underwent operation on an
emergency basis. In the second case, initial stabilization allowed
us to postpone surgery.
The question as to whether mitral valve repair is preferable to
replacement in acute ischemic mitral insufficiency is still unan-
swered. Grossi and colleagues4 and Gillinov and associates5 re-
Figure 1. Transesophageal echocardiogram showing restrictive systolic motion of anterior and posterior leaflets
with reduced coaptation. LA, Left atrium; LV, left ventricle; ECG, electrocardiogram.
Figure 2. Color Doppler echocardiographic imaging demonstrating grade mitral regurgitation resulting from
systolic restriction with reduced coaptation. ECG, Electrocardiogram.
Brief Communications
The Journal of Thoracic and Cardiovascular Surgery ● Volume 126, Number 1 285
ported similar survivals after replacement versus repair in patients
with complex and acute mitral regurgitation. However, preference
of the operating surgeon certainly introduced selection bias in
these retrospective studies.
It has been established that preservation of the subvalvular
apparatus positively influences postoperative left ventricular
function. Therefore in cases where mitral valve surgery is
proposed as a lifesaving procedure, we believe, as illustrated by
the cases reported here, that a successful mitral valve repair is
preferable, especially in the absence of papillary muscle rup-
ture. In our hands RMA has proved its value in curing chronic
ischemic mitral insufficiency by restoring an adequate height of
leaflet coaptation.2 Similarly, we believe that the stress in the
subvalvular apparatus can also be reduced by this technique in acute
cases, thereby decreasing the risk of postrepair rupture of the infarcted
myocardium.
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